Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 937

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 3
Chunk 937
---
,772  
     13,923  
     10,746  
     71,356 
  
    Accounts payable and accrued expenses 
     1,007,618  
     1,007,618  
     -  
     -  
     - 
  
    Total 
    $1,262,415  
    $1,016,390  
    $17,544  
    $17,545  
    $210,936 

Amounts related to contingent milestone payments
are not considered contractual obligations as they are contingent on the achievement of certain milestones. These contingent milestones
may or may not be achieved. We have not included any of these amounts in the table above as we cannot estimate or predict when, or if,
these amounts will become due.

Cash Flows

    Year Ended December 31,  

    2024  
    2023  
    $ Change  
    % Change 
  
    Net Cash (Used In) Provided By : 

    Operating Activities 
    $(5,648,088) 
    $(4,542,910) 
    $(1,105,178) 
     24.33%
  
    Investing Activities 
     (1,889,114) 
     (115,888) 
     (1,773,226) 
     1,530.12 
  
    Financing Activities 
     7,053,571  
     6,474,565  
     579,006  
     8.94 
  
    Effect of Foreign Currency Translation on Cash Flow 
     499  
     61,853  
     (61,354) 
     (99.19)
  
    Net (Decrease) Increase in Cash and Cash Equivalents 
    $(483,132) 
    $1,877,620  
    $(2,360,752) 
     (125.73)%

Cash Used in Operating Activities

Net cash used in operating activities was $5,648,088
for the year ended December 31, 2024, as compared to $4,542,910 for the year ended December 31, 2023. Our net cash used in operating
activities increased, in part due to higher general and administrative expenses of $5,024,985 for the year ended December 31, 2024 ($4,